The global Bone Densitometers Market Growth Accelerated by Growing Geriatric Population


 Bone densitometers, also known as bone densitometers, are medical devices that are used to measure bone density and diagnose bone related disorders like osteopenia and osteoporosis. They help in early detection of bone loss and prevention of fractures. These devices are highly beneficial for monitoring bone health and density diagnosis in geriatric population.


The global Bone Densitometers Market is estimated to be valued at US$ 313.05 Mn in 2023 and is expected to exhibit a CAGR of 4.7% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.

Market key trends:
Growing geriatric population is a key trend driving the growth of bone densitometers market. According to World Health Organization data, the world's population aged 65 years and above is anticipated to nearly double from 703 million in 2019 to 1.5 billion in 2050. Osteoporosis effects more than 200 million women worldwide and can lead to weak bones and increased risk of fractures. With rise in aged population, prevalence of osteoporosis and related fractures is also increasing significantly. Growing health concerns in elderly population and need for early and effective diagnosis of bone disorders is fueling adoption of bone densitometer devices globally. This is propelling the market growth substantially over the forecast period.


Segment Analysis
The global bone densitometers market is segmented by technology, application and end user. Based on technology, dual energy X-ray absorptiometry (DXA) dominates the market. It is considered the gold standard for measuring bone mineral density as it exposes patients to very low radiation and provides highly accurate and precise bone density readings.

Key Takeaways
The global bone densitometers market is expected to witness high growth. The global Bone Densitometers Market is estimated to be valued at US$ 313.05 Mn in 2023 and is expected to exhibit a CAGR of 4.7% over the forecast period 2023 to 2030.
Regional analysis
North America is expected to maintain its dominance in the global market during the forecast period. This is attributed to increasing healthcare expenditures and growing awareness regarding osteoporosis diagnosis and management in countries such as the US and Canada.

Key players
Key players operating in the bone densitometers market are GE Healthcare, Hologic, Inc., Swissray Global Healthcare Holding, and BeamMed Ltd. GE Healthcare holds the largest share in global market due to its diversified product portfolio. Hologic, Inc. specializes in bone health and focuses on developing novel DXA systems to strengthen its market position.

Comments

Post a Comment

Popular posts from this blog

Unveiling Health Secrets: Exploring the Potential of Blood-Based Biomarkers

Image
  The human body is a complex and intricate system, often harboring subtle signs of its inner workings. One of the most promising avenues for unlocking these secrets lies within our bloodstream – a treasure trove of information encoded in the form of blood-based biomarkers. These biomarkers, measurable indicators present in the blood, hold the potential to revolutionize healthcare by providing early detection, accurate diagnosis, and personalized treatment approaches. Blood-based biomarkers encompass a wide range of molecules – from proteins and nucleic acids to metabolites and even circulating cells. Researchers have been diligently working to identify specific biomarkers associated with various diseases and conditions. For instance, elevated levels of certain proteins might point to cardiovascular diseases, while specific genetic material could indicate the presence of cancer. By analyzing these biomarkers, clinicians gain valuable insights into an individual's health status, en...
Read more

Revolutionizing Biology: Advancements in Single Cell Analysis Techniques

Image
  Single cell analysis has emerged as a groundbreaking technology that is revolutionizing the field of biology. Traditionally, biological studies were conducted on populations of cells, averaging out the heterogeneity present within them. However, the advent of single cell analysis has enabled scientists to delve into the complexity of individual cells, uncovering a wealth of previously inaccessible information. Advancements in single cell analysis techniques have paved the way for a deeper understanding of cellular heterogeneity, gene expression, and cellular behavior. One of the most remarkable techniques is single-cell RNA sequencing (scRNA-seq), which allows scientists to measure gene expression in individual cells. This breakthrough has led to the identification of rare cell types, understanding of cellular communication networks, and the discovery of novel biomarkers. Moreover, single cell imaging techniques, such as single cell fluorescence microscopy, have enabled research...
Read more

Medical Robots Market Poised to Grow Owing to Improving Healthcare Infrastructure

Image
 The Medical Robots Market is anticipated to witness robust growth due to rising healthcare spending across the globe. Medical robots are used to perform minimal invasive surgeries with greater accuracy and flexibility. Growing preference for Robot-Assisted Surgery (RAS) over conventional open surgeries due to benefits such as shorter recovery time and minimum operative scars has been augmenting demand for medical robots. Key functions include guiding and positioning surgical accessories like guide tubes in radiology and guiding catheter and wires in cardiology. With rising chronic disease prevalence associated with aging populations, the need for more surgical procedures is surging which requires precise action minimally invasive robotic systems can provide. The Global Medical Robots Market is estimated to be valued at US$ 11.47 Bn in 2024 and is expected to exhibit a CAGR of 16% over the forecast period 2023 to 2030. Key Takeaways: Key players operating in the Medical Robo...
Read more